PMGC HOLDINGS INC. Operating Lease Liability
PMGC HOLDINGS INC. (ELAB) had Operating Lease Liability of $4.84 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-08-14
- 2026-06-30: Operating Lease, Liability $4.84M.
- 2026-03-31: Operating Lease, Liability $2.23M.
- 2025-12-31: Operating Lease, Liability $1.22M.
- 2025-09-30: Operating Lease, Liability $1.21M.
| Period end | Operating Lease, Liability |
|---|---|
| 2026-06-30 | $4.84M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $2.23M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.22M 10-K · filed 2026-03-30 |
| 2025-09-30 | $1.21M 10-Q · filed 2025-11-14 |
| 2024-09-30 | $103.31K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $140.06K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $175.78K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $210.49K 10-K · filed 2024-03-29 |
| 2023-09-30 | $103.31M 10-Q · filed 2023-12-11 |
| 2022-12-31 | $172.60M 10-Q · filed 2023-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |